Status:

COMPLETED

Investigation of the Effects of Technology Supported Different Physiotherapy Approaches on Patients With Multiple Sclerosis

Lead Sponsor:

Hacettepe University

Conditions:

Multiple Sclerosis

Eligibility:

All Genders

18-50 years

Phase:

NA

Brief Summary

Multiple Sclerosis (MS) is an autoimmune disease characterized by chronic inflammation, demyelination and axonal loss of the central nervous system. The etiology of the disease is not known exactly an...

Eligibility Criteria

Inclusion

  • Diagnosed with Relapsing Remitting, Primary Progressive or Secondary Progressive MS according to McDonald criteria,
  • Between the age of 18 and 50 years
  • EDSS score greater than 2, less than 5.5,
  • Mini Mental State Test score of 24 and above,
  • Volunteers who have access to smartphone (mobile phone) through themselves or their relatives will be included in the study.

Exclusion

  • Surgery or botox application for spasticity in the last 6 months,
  • Having an attack history in the last 3 months,
  • Received physical therapy and rehabilitation services in the last 6 months,
  • Any pain in any part of the body, previous surgery, any orthopedic problem,
  • Have a secondary neurological, orthopedic or systematic condition that prevents standing independently,
  • With severe peripheral vestibular involvement,
  • EDSS- Pyramidal functions score equal to and greater than 4,
  • Patients who do not agree to participate in the study and do not give written consent will not be included in the study.

Key Trial Info

Start Date :

February 16 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 17 2022

Estimated Enrollment :

34 Patients enrolled

Trial Details

Trial ID

NCT04891341

Start Date

February 16 2021

End Date

July 17 2022

Last Update

July 19 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Mert Doğan

Ankara, Altındağ, Turkey (Türkiye), 06100